CADTH rapid response review: Safety of leflunomide and methotrexate as combination therapy for rheumatoid arthritis
Source: Canadian Agency for Drugs and Technologies in Health (CADTH) Area: News The Canadian Agency for Drugs and Technologies in Health (CADTH) Rapid Response Service has produced a review of the evidence on the safety of leflunomide and methotrexate as combination therapy for rheumatoid arthritis. The evidence was limited and definitive conclusions were not possible. One RCT in a systematic review on DMARDs and one non-randomised study on DMARDs suggested an increased risk of abnormal liver function for treatment with the combination. nbsp; Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources and a summary of the best evidence on the topic that CADTH could identify using all reasonable eff...

Eczema tied to higher impotence risk
NEW YORK (Reuters Health) - Men who have the allergic skin condition eczema may have a higher risk of erectile dysfunction than other men, a new study finds. (Source: Reuters: Health)